Cardio-oncology (London, England)

Keyphrases

Publications

volume 10, number 1, 2024

Georgia Thomas, Elisabeth Weiss, Marco Giuseppe Del Buono, Francesco Moroni, Josh West, Rachel Myers, Emily Kontos, Michele Golino, Antonio Abbate, Justin M Canada
Early reduction in cardiorespiratory fitness and diastolic reserve following radiation therapy for lung cancer. Cardio-oncology (London, England) 10 (1) (2024)
S Mori, M Bertamino, L Guerisoli, S Stratoti, C Canale, P Spallarossa, I Porto, P Ameri
Pericardial effusion in oncological patients: current knowledge and principles of management. Cardio-oncology (London, England) 10 (1) (2024)
Ahmed Mazen Amin, Yehya Khlidj, Mohamed Abuelazm, Ahmed A Ibrahim, Mohammad Tanashat, Muhammad Imran, Abubakar Nazir, Hosam Shaikhkhalil, Basel Abdelazeem
The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. Cardio-oncology (London, England) 10 (1) (2024)
Mantasha Tabassum, Soumya G Chikermane, Camille Johnson, Noor M Abdulkareem, Elisabeth M Wang, Michael L Johnson, Meghana V Trivedi
Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients. Cardio-oncology (London, England) 10 (1) (2024)
Juan Del Cid Fratti, Vijayasree Paleru, Madhuri Bajaj, Chetan Bhardwaj
Correction: The toxic tango: TKI and ICI cardiotoxicities. Cardio-oncology (London, England) 10 (1) (2024)
Azin Alizadehasl, Mina Mohseni, Kamran Roudini, Parisa Firoozbakhsh
Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction. Cardio-oncology (London, England) 10 (1) (2024)
Anna Talty, Roseanne Morris, Carolyn Deighan
Home-based self-management multimodal cancer interventions & cardiotoxicity: a scoping review. Cardio-oncology (London, England) 10 (1) (2024)
Anna Talty, Roseanne Morris, Carolyn Deighan
Home-based self-management multimodal cancer interventions & cardiotoxicity: a scoping review. Cardio-oncology (London, England) 10 (1) (2024)
Arsalan Hamid, Gregg C Fonarow, Javed Butler, Michael E Hall
How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized? Cardio-oncology (London, England) 10 (1) (2024)
Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M Okwuosa
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study. Cardio-oncology (London, England) 10 (1) (2024)
Nathanya Baez Hernandez, Ksenya Shliakhtsitsava, Drishti Tolani, Cindy Cochran, Ryan Butts, Judith Bonifacio, Elizabeth Journey, Jenna N Oppenheim, Sarah G Pennant, Kimberly Arnold, Terri McCaskill, Daniel C Bowers
A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors. Cardio-oncology (London, England) 10 (1) (2024)
Moran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, Yasmin Leshem, Or Bainhoren, Tammi Arbel Rubinstein, Maxim Perelman, Zach Rozenbaum, Ofer Havakuk, Yan Topilsky, Shmuel Banai, Ido Wolf, Michal Laufer-Perl
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors. Cardio-oncology (London, England) 10 (1) (2024)
Anders W Bjerring, Knut Hb Smeland, Thomas Stokke, Kristina H Haugaa, Espen Holte, Assami Rösner, Cecilie E Kiserud, Thor Edvardsen, Sebastian Imre Sarvari
Long-term cardiac effects of modern treatment for Hodgkin's lymphoma. Cardio-oncology (London, England) 10 (1) (2024)
Massimiliano Camilli, Marcello Viscovo, Tamara Felici, Luca Maggio, Federico Ballacci, Giacomo Carella, Alice Bonanni, Priscilla Lamendola, Lorenzo Tinti, Antonio Di Renzo, Giulia Coarelli, Eugenio Galli, Giovanna Liuzzo, Francesco Burzotta, Rocco Antonio Montone, Federica Sorà, Simona Sica, Stefan Hohaus, Gaetano Antonio Lanza, Filippo Crea, Antonella Lombardo, Giorgio Minotti
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study. Cardio-oncology (London, England) 10 (1) (2024)
Massimiliano Camilli, Marcello Viscovo, Tamara Felici, Luca Maggio, Federico Ballacci, Giacomo Carella, Alice Bonanni, Priscilla Lamendola, Lorenzo Tinti, Antonio Di Renzo, Giulia Coarelli, Eugenio Galli, Giovanna Liuzzo, Francesco Burzotta, Rocco Antonio Montone, Federica Sorà, Simona Sica, Stefan Hohaus, Gaetano Antonio Lanza, Filippo Crea, Antonella Lombardo, Giorgio Minotti
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study. Cardio-oncology (London, England) 10 (1) (2024)
Isabelle Senechal, Maria Sol Andres, Jieli Tong, Ylenia Perone, Sivatharshini Ramalingam, Muhummad Sohaib Nazir, Stuart D Rosen, Nicholas Turner, Alistair Ring, Alexander R Lyon
Late cardiotoxicity related to HER2-targeted cancer therapy. Cardio-oncology (London, England) 10 (1) (2024)
Ahmed A Fawzy, Khaled A El-Menyawi, Walid M Sallam, Mohamed E Zahran
Two-dimensional speckle tracking echocardiography in chemotherapy-induced cardiotoxicity in females with breast cancer. Cardio-oncology (London, England) 10 (1) (2024)
Ahmed Mazen Amin, Yehya Khlidj, Mohamed Abuelazm, Ahmed A Ibrahim, Mohammad Tanashat, Muhammad Imran, Abubakar Nazir, Hosam Shaikhkhalil, Basel Abdelazeem
The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. Cardio-oncology (London, England) 10 (1) (2024)
Georgia Thomas, Elisabeth Weiss, Marco Giuseppe Del Buono, Francesco Moroni, Josh West, Rachel Myers, Emily Kontos, Michele Golino, Antonio Abbate, Justin M Canada
Early reduction in cardiorespiratory fitness and diastolic reserve following radiation therapy for lung cancer. Cardio-oncology (London, England) 10 (1) (2024)
Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M Okwuosa
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study. Cardio-oncology (London, England) 10 (1) (2024)
Yvonne Koop, Femke Atsma, Marilot C T Batenburg, Hanneke Meijer, Femke van der Leij, Roxanne Gal, Sanne G M van Velzen, Ivana Išgum, Hester Vermeulen, Angela H E M Maas, Saloua El Messaoudi, Helena M Verkooijen
Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost. Cardio-oncology (London, England) 10 (1) (2024)
Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M Okwuosa
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study. Cardio-oncology (London, England) 10 (1) (2024)
S Mori, M Bertamino, L Guerisoli, S Stratoti, C Canale, P Spallarossa, I Porto, P Ameri
Pericardial effusion in oncological patients: current knowledge and principles of management. Cardio-oncology (London, England) 10 (1) (2024)
Jian Chu, Lillian Tung, Issam Attalah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M Okwuosa
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study. Cardio-oncology (London, England) 10 (1) (2024)
Jian Chu, Lillian Tung, Issam Attalah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M Okwuosa
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study. Cardio-oncology (London, England) 10 (1) (2024)
Nathanya Baez Hernandez, Ksenya Shliakhtsitsava, Drishti Tolani, Cindy Cochran, Ryan Butts, Judith Bonifacio, Elizabeth Journey, Jenna N Oppenheim, Sarah G Pennant, Kimberly Arnold, Terri McCaskill, Daniel C Bowers
A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors. Cardio-oncology (London, England) 10 (1) (2024)
Sinal Patel, Francisco X Franco, Malcolm McDonald, Carlos Rivera, Bernardo Perez-Villa, Patrick Collier, Rohit Moudgil, Neha Gupta, Diego B Sadler
Use of computed tomography coronary calcium score for prediction of cardiovascular events in cancer patients: a retrospective cohort analysis. Cardio-oncology (London, England) 10 (1) (2024)
Kundan Chufal, Irfan Ahmad, Anuj Prakash, Alexis Miller, Preetha Umesh, Varsha Koul, Ram Bajpai, Bharat Dua, Priya Gupta, Munish Gairola
Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study. Cardio-oncology (London, England) 10 (1) (2024)
Anders W Bjerring, Knut Hb Smeland, Thomas Stokke, Kristina H Haugaa, Espen Holte, Assami Rösner, Cecilie E Kiserud, Thor Edvardsen, Sebastian Imre Sarvari
Long-term cardiac effects of modern treatment for Hodgkin's lymphoma. Cardio-oncology (London, England) 10 (1) (2024)
Kundan Chufal, Irfan Ahmad, Anuj Prakash, Alexis Miller, Preetha Umesh, Varsha Koul, Ram Bajpai, Bharat Dua, Priya Gupta, Munish Gairola
Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study. Cardio-oncology (London, England) 10 (1) (2024)
Mantasha Tabassum, Soumya G Chikermane, Camille Johnson, Noor M Abdulkareem, Elisabeth M Wang, Michael L Johnson, Meghana V Trivedi
Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients. Cardio-oncology (London, England) 10 (1) (2024)
Massimiliano Camilli, Marcello Viscovo, Tamara Felici, Luca Maggio, Federico Ballacci, Giacomo Carella, Alice Bonanni, Priscilla Lamendola, Lorenzo Tinti, Antonio Di Renzo, Giulia Coarelli, Eugenio Galli, Giovanna Liuzzo, Francesco Burzotta, Rocco Antonio Montone, Federica Sorà, Simona Sica, Stefan Hohaus, Gaetano Antonio Lanza, Filippo Crea, Antonella Lombardo, Giorgio Minotti
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study. Cardio-oncology (London, England) 10 (1) (2024)
Azin Alizadehasl, Mina Mohseni, Kamran Roudini, Parisa Firoozbakhsh
Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction. Cardio-oncology (London, England) 10 (1) (2024)
Karen Abboud, Godsfavour Umoru, Barry Trachtenberg, Veronica Ajewole
Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics. Cardio-oncology (London, England) 10 (1) (2024)
Isabelle Senechal, Maria Sol Andres, Jieli Tong, Ylenia Perone, Sivatharshini Ramalingam, Muhummad Sohaib Nazir, Stuart D Rosen, Nicholas Turner, Alistair Ring, Alexander R Lyon
Late cardiotoxicity related to HER2-targeted cancer therapy. Cardio-oncology (London, England) 10 (1) (2024)
Isabelle Senechal, Maria Sol Andres, Jieli Tong, Ylenia Perone, Sivatharshini Ramalingam, Muhummad Sohaib Nazir, Stuart D Rosen, Nicholas Turner, Alistair Ring, Alexander R Lyon
Late cardiotoxicity related to HER2-targeted cancer therapy. Cardio-oncology (London, England) 10 (1) (2024)
Ahmed A Fawzy, Khaled A El-Menyawi, Walid M Sallam, Mohamed E Zahran
Two-dimensional speckle tracking echocardiography in chemotherapy-induced cardiotoxicity in females with breast cancer. Cardio-oncology (London, England) 10 (1) (2024)
Georgia Thomas, Elisabeth Weiss, Marco Giuseppe Del Buono, Francesco Moroni, Josh West, Rachel Myers, Emily Kontos, Michele Golino, Antonio Abbate, Justin M Canada
Early reduction in cardiorespiratory fitness and diastolic reserve following radiation therapy for lung cancer. Cardio-oncology (London, England) 10 (1) (2024)
Maciej Kabat, Roma Padalkar, Sara Hazaveh, Vladimir Joseph, David Feigenblum, Sean Sadikot
Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest. Cardio-oncology (London, England) 10 (1) (2024)
Maciej Kabat, Roma Padalkar, Sara Hazaveh, Vladimir Joseph, David Feigenblum, Sean Sadikot
Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest. Cardio-oncology (London, England) 10 (1) (2024)
Bartosz Puła, Jarosław Kępski, Irena Misiewicz-Krzemińska, Sebastian Szmit
Left and right ventricular global longitudinal strain assessment together with biomarker evaluation may have a predictive and prognostic role in patients qualified for hematopoietic stem cell transplantation due to hematopoietic and lymphoid malignancies - a pilot study description. Cardio-oncology (London, England) 10 (1) (2024)
Karen Abboud, Godsfavour Umoru, Barry Trachtenberg, Veronica Ajewole
Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics. Cardio-oncology (London, England) 10 (1) (2024)
Arsalan Hamid, Gregg C Fonarow, Javed Butler, Michael E Hall
How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized? Cardio-oncology (London, England) 10 (1) (2024)
Yvonne Koop, Femke Atsma, Marilot C T Batenburg, Hanneke Meijer, Femke van der Leij, Roxanne Gal, Sanne G M van Velzen, Ivana Išgum, Hester Vermeulen, Angela H E M Maas, Saloua El Messaoudi, Helena M Verkooijen
Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost. Cardio-oncology (London, England) 10 (1) (2024)
Isabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, Jieli Tong, Sivatharshini Ramalingam, Stuart D Rosen, Alexander R Lyon, Muhummad Sohaib Nazir
Cancer therapy related cardiac dysfunction as a result of Panitumumab. Cardio-oncology (London, England) 10 (1) (2024)
Isabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, Jieli Tong, Sivatharshini Ramalingam, Stuart D Rosen, Alexander R Lyon, Muhummad Sohaib Nazir
Cancer therapy related cardiac dysfunction as a result of Panitumumab. Cardio-oncology (London, England) 10 (1) (2024)
Bartosz Puła, Jarosław Kępski, Irena Misiewicz-Krzemińska, Sebastian Szmit
Left and right ventricular global longitudinal strain assessment together with biomarker evaluation may have a predictive and prognostic role in patients qualified for hematopoietic stem cell transplantation due to hematopoietic and lymphoid malignancies - a pilot study description. Cardio-oncology (London, England) 10 (1) (2024)
Juan Del Cid Fratti, Vijayasree Paleru, Madhuri Bajaj, Chetan Bhardwaj
Correction: The toxic tango: TKI and ICI cardiotoxicities. Cardio-oncology (London, England) 10 (1) (2024)
Moran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, Yasmin Leshem, Or Bainhoren, Tammi Arbel Rubinstein, Maxim Perelman, Zach Rozenbaum, Ofer Havakuk, Yan Topilsky, Shmuel Banai, Ido Wolf, Michal Laufer-Perl
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors. Cardio-oncology (London, England) 10 (1) (2024)
Sinal Patel, Francisco X Franco, Malcolm McDonald, Carlos Rivera, Bernardo Perez-Villa, Patrick Collier, Rohit Moudgil, Neha Gupta, Diego B Sadler
Use of computed tomography coronary calcium score for prediction of cardiovascular events in cancer patients: a retrospective cohort analysis. Cardio-oncology (London, England) 10 (1) (2024)